HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 196 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $92 | -99.9% | 2,416 | -21.0% | 0.00% | – |
| Q4 2021 | $122,000 | +351.9% | 3,057 | +386.0% | 0.00% | – |
| Q4 2020 | $27,000 | -22.9% | 629 | -51.7% | 0.00% | – |
| Q2 2020 | $35,000 | -64.3% | 1,302 | -76.2% | 0.00% | -100.0% |
| Q1 2020 | $98,000 | -80.9% | 5,465 | -81.1% | 0.00% | -50.0% |
| Q4 2019 | $512,000 | +196.0% | 28,896 | +186.3% | 0.00% | +100.0% |
| Q2 2019 | $173,000 | -4.4% | 10,094 | -10.2% | 0.00% | 0.0% |
| Q1 2019 | $181,000 | -77.1% | 11,246 | -74.1% | 0.00% | -66.7% |
| Q3 2018 | $789,000 | -45.6% | 43,469 | -49.5% | 0.00% | -50.0% |
| Q2 2018 | $1,451,000 | -80.8% | 86,061 | -77.7% | 0.01% | -81.8% |
| Q1 2018 | $7,572,000 | +151340.0% | 386,420 | +188397.6% | 0.03% | – |
| Q2 2015 | $5,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |